Sick euthyroid syndrome

Journal of Intensive Care Medicine

Volumn 12, Issue 5, 1997, Pages 249-260

  Farwell, Alan P ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; THYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

CRITICAL ILLNESS; EUTHYROIDISM; HUMAN; PRIORITY JOURNAL; REVIEW; SYNDROME; THYROID HORMONE BLOOD LEVEL;

EID: 0030772710     PISSN: 08850666     EISSN: None     Source Type: Journal    
DOI: 10.1177/088506669701200505     Document Type: Review

References (118)

1. Chopra IJ, Hershman JH, Pardridge WM, Nicoloff JT. Thyroid function in nonthyroidal illness. Ann Intern Med 1983;98:926-957
2. Kaptein EM. Thyroid hormone metabolism in illness. In: Hennemann G, ed. Thyroid hormone metabolism. New York: Marcel Dekker, 1986;297-333
3. Docter R, Krenning EP, de Jong M, Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxford) 1993;39:499-518
4. Nicoloff JT, Lopresti JS. Nonthyroidal illness. In: Braverman LE, Utiger RD. eds. The thyroid, ed 7. Philadelphia: Lippincott-Raven, 1996;286-296
5. Farwell AP. Sick euthyroid syndrome in the intensive care unit. In: Rippe JM, Irwin RS, Fink MP, Cerra FB, eds. Intensive care medicine. Boston: Little, Brown, 1996:1347-1353
6. McIver B, Gorman CA. Euthyroid sick syndrome: an overview. Thyroid 1997;7:125-132
7. Chopra IJ. Euthyroid sick syndrome: abnormalities in circulating thyroid hormones and thyroid hormone physiology in nonthyroidal illness. Med Grand Rounds 1982;1:201-212
8. Morley JE, Slag MF, Elson MK, Shafer RB. The interpretation of thyroid function tests in hospitalized patients. JAMA 1983;249:2377-2379
9. Fujii T, Sato K, Ozawa M, et al. Effect of interleukin-1 (Il-1) on thyroid horone metabolism in mice: stimulation by Il-1 of iodothyronine 5′-deiodinating activity (type I) in the liver. Endocrinology 1989;124:167-174
10. Bartalena L, Grasso L, Brogioni S, Martino E. Interleukin 6 effects on the pituitary-thyroid axis in the rat. Fur J Endocrinol 1994;131:302-306
11. Corssmit EPM, Heyligenberg R, Endert E, Sauerwein HP. Acute effects of interferon-α administration on thyroid hormone metabolism in healthy men. J Clin Endocrinol Metab 1995;80:3140-3144
12. Boelen A, Platvoetter Shiphorst MC, Bakker O, Wiersinga WM. The role of cytokines in the lipopolysaccharide- induced sick euthyroid syndrome in mice. J Endocrinol 1995;146:475-483
13. Dubuis JM, Dayer J-M, Seigrist-Kaiser CA, Burger AG. Human recombinant interleukin-1β decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats. Endocrinology 1988;123:2175-2181
14. Hermus ARMM, Sweep CGJ, van der Meer MJM, et al. Continuous infusion of interleukin-1β induces a nonthyroidal illness syndrome in the rat. Endocrinology 1992;131:2139-2146
15. Pang X-P, Hershman JM, Mirell CJ. Impairment of hypothalamic-thyroid function in rats treated with human recombinant tumor necrosis factor α. Endocrinology 1989; 125:76-84
16. Stouthard JML, van der Poll T, Endert E, et al. Effects of acute and chronic interleukin-6 administration on thyroid homrone metabolism in humans. J Clin Endocrinol Metab 1994;79:1342-1346
17. van der Poll F, Romijn JA. Wiersinga WM, Sauerwein HP. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990;71:1567-1572
18. Larsen PR, Silva JE, Kaplan MM. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocrinol Rev 1981;2:87-102
19. Koehrle J, Brabant G, Hesch RD. Metabolism of thyroid hormones. Hormone Res 1987;26:58-78
20. Chopra IJ. Nature, source and relative significance of circulating thyroid hormones. In: Braverman LE, Utiger RD, eds. The thyroid. Philadelphia: Lippincott-Raven, 1996:111-124
21. Leonard JL, Visser TJ. Biochemistry of deiodination. In: Hennemann G, ed. Thyroid hormone metabolism. New York: Marcel Dekker, 1986:189-230
22. Leonard JL, Koehrle J. Intracellular pathways of iodothyronine metabolism. In: Braverman LE, Utiger RD, eds. The thyroid. Philadelphia: Lippincott-Raven, 1996:125-161
23. Burger A. Nondeiodinative pathways of thyroid hormone metabolism. In: Hennemann G, ed. Thyroid hormone metabolism. New York: Marcel Dekker, 1986;255-276
24. Chopra IS, Santini F, Wu S, Hind RE. The role of sulfation and desulfation in thyroid hormone metabolism. In: Wu S, Visser TS, eds. Thyroid hormone metabolism. Boca Raton, FL: CRC Press, 1994:119-138
25. Robbins J, Thyroid hormone transport proteins and the physiology of hormone binding. In: Braverman LE, Utiger RD, eds. The thyroid, ed 6. Philadelphia: J. B. Lippincott, 1991:111-125
26. Chopra IJ, Huang T-S, Beredo A, et al. Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3′- triiodothyronine in sera of patients with nonthyroidal illness. J Clin Endocrinol Metab 1985;60:666-672
27. Chopra IJ, Chopra U, Smith SR, et al. Reciprocal changes in serum concentrations of 3,3′5′-triiodothyronine (reverse T3) and 3,3′,5′-triiodothyronine (T3) in systemic illnesses. J Clin Endocrinol Metab 1975;41:1043-1049
28. Nicoloff JT, LoPresti J. An integrated assessment of prereceptor regulation of thyroid hormone metabolism. In: Wu S-Y, Visser TJ, eds. Thyroid Hormone Metabolism. Boca Raton: CRC Press, 1994:75-84
29. Faber J, Kirkegaard C, Rasmussen B, et al. Pituitary-thyroid axis in critical illness. J Clin Endocrinol Metab 1987; 65:315-320
30. Kaptein EM, Weiner JM, Robinson WJ, et al. Relationship of altered thyroid hormone indices to survival in nonthyroidal illness. Clin Endocrinol (Oxf) 1982;16:565-574
31. Van den Berghe G, de Zegher F, Lauwers P. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf) 1994;41:731-737
32. Kaptein EM, Spencer CA, Kamiel MB, Nicoloff JT. Prolonged dopamine administration and thyroid hormone economy in normal and critically ill subjects. J Clin Endocrinol Metab 1980;51:387-393
33. Adriaanse R, Romijin JA, Brabant G, et al. Pulsatile thyrotropin secretion in nonthyroidal illness. J Clin Endocrinol Metab 1993;77:1313-1317
34. Romijin JA, Wiersinga WM. Decreased nocturnal surge of thyrotropin in nonthyroidal illness. J Clin Endocrinol Metab 1990;70:35-42
35. Jackson IM. Thyrotropin-releasing hormone. N Engl J Med 1982;306:145-155
36. Chopra IJ, Santini F, Wu S-Y, Hurd RE. The role of sulfation and desulfation in thyroid hormone metabolism. In: Wu S-Y, Visser TJ, eds. Thyroid Hormone Metabolism. Boca Raton: CRC Press, 1994:119-138
37. Bellabarba D, Inada M, Varsano-Aharon N, Sterling K. Thyroxine transport and turnover in major nonthyroidal illness. J Clin Endocrinol Metab 1968;28:1023-1030
38. Yamanaka T, Ido K, Kimura K, Saito T. Serum levels of thyroid hormones in liver diseases. Clin Chim Acta 1980;101:45-55
39. LoPresti JS, Fried JC, Spencer CA, Nicoloff JT. Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989;110:970-975
40. Kaptein EM, Grieb DA, Spencer CA, et al. Thyroxine metabolism in the low thyroxine state of critical nonthyroidal illness. J Clin Endocrinol Metab 1981;53:764-771
41. Chopra IJ, Solomon DH, Hepner GW, Morgenstein AA. Misleadingly low free thyroxine index and usefulness of reverse triiodothyronine measurement in nonthyroidal illness. Ann Intern Med 1979;90:905-912
42. Oppenheimer JH, Schwartz HL, Mariash CN, Kaiser FE. Evidence for a factor in the sera of patients with nonthyroidal disease which inhibits iodothyronine binding to solid matrices, serum proteins, and rat hepatocytes. J Clin Endocrinol Metab 1982;54:757-766
43. Lim CF, Munro SL, Wynne KN, et al. Influence of non-esterified fatty acids and lysolecithins on thyroxine binding to thyroxine-binding globulin and transthyretin. Thyroid 1995;4:319-324
44. Chopra IJ, Huang T-S, Solomon DH, et al. The role of T4- binding serum proteins in oleic acid-induced increase in free T4 in nonthyroidal illnesses. J Clin Endocrinol Metab 1986;63:776-779
45. Lim CF, Docter R, Visser TJ, et al. Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and non-esterified fatty acids. J Clin Endocrinol Metab 1993;76:1165-1172
46. Stockigt JR, Lim CF, Barlow JW, et al. High concentrations of furosemide inhibit serum binding of thyroxine. J Clin Endocrinol Metab 1984;59:62-66
47. Burger AG. Effects of phamacological agents on thyroid hormone metabolism. In: Braverman LE, Utiger RD, eds. The thyroid, ed 6. Philadelphia: J. B. Lippincott, 1991; 335-346
48. Surks MI, Chopra IJ, Mariash CN, et al. American Thyroid Association guidelines for the use of laboratory tests in thyroid disease. JAMA 1990;263:1529-1532
49. Nelson JC, Weiss RM. The effect of serum dilution on free thyroxine concentration in the low T4 syndrome of nonthyroidal illness. J Clin Endocrinol Metab 1985;61:239-246
50. Bermudez F, Surks MI, Oppenheimer JH. High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease. J Clin Endocrinol Metab 1975;41:27-40
51. Spencer CA. Clinical utility and cost-effectiveness of sensitive thyrotropin assays in ambulatory and hospitalized patients. Mayo Clin Proc 1988;63:1214-1222
52. Spencer C, Eigen A, Shen D, et al. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 1987;33: 1391-1396
53. Kaptein EM, Robinson WJ, Grieb DA, Nicoloff JT. Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illness. J Clin Invest 1982;69:526
54. Kaptein EM, Feinstein EI, Nicoloff JT, Massry SG. Serum reverse triiodothyronine and thyroxine kinetics in patients with chronic renal failure. J Clin Endocrinol Metab 1983;57:181-189
55. Burrows AW, Shakespear RA, Hesch RD, et al. Thyroid hormones in the elderly sick: "T4 euthyroidism." Br Med J 1975;4:437-439
56. Spratt DI, Pont A, Miller MB, et al. Hyperthyroxinemia in patients with acute psychiatric disorders. Am J Med 1982;73:41-48
57. Slag MF, Morley JE, Elson MK, et al. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 1981;245:43-45
58. Maldonado LS, Murata GH, Hershman JM, Braunstein GD. Do thyroid function tests independently predict survival in the critically ill? Thyroid 1992;2:119-123
59. Kaptein EM, Macintyre SS, Weiner JM, et al. Free thyroxine estimates in nonthyroidal illness: comparison of eight methods. J Clin Endocrinol Metab 1981;54:1073-1077
60. Slag MF, Morley JE, Elson MK, et al. Free thyroxine levels in critically ill patients. A comparison of currently available assays. JAMA 1981;246:2702-2706
61. Hamblin S, Dyer SA, Mohr VS, et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab 1986;62:717-722
62. Rees RC. Cytokines as biological response modifiers. Clin Pathol 1992;45:93-98
63. Hashimoto H, Igarashi N, Yachie A, et al. The relationship between serum levels of interleukin-6 and thyroid hormone in children with acute respiratory infection. J Clin Endocrinol Metab 1994;78:288-291
64. Mooradian AD, Reed RL, Osterweil D, et al. Decreased serum triiodothyronine is associated with increased concentrations of tumor necrosis factor. J Clin Endocrinol Metab 1990;71:1239-1242
65. Chopra IJ, Sakane S, Chua Teco GN. A study of the serum concentration of tumor necrosis factor-α in thyroidal and nonthyroidal illness. J Clin Endocrinol Metab 1991;72: 1113-1116
66. Tang K-T, Braverman LE, DeVito WJ. Tumor necrosis factor- α and interferon-γ modulate gene expression of type I 5′-deiodinase, thyroid peroxidase and thyroglobulin in FRTL-5 rat thyroid cells. Endocrinology 1995;136:881-888
67. Pekary AF, Berg L, Santini F, Chopra I, Hershman JE. Cytokines modulate type I iodothyronine deiodinase mRNA levels and enzyme activity in FRTL-5 rat thyroid cells. Mol Cell Endocrinol 1994;101:R31-R35
68. Enomoto T, Sugawa H, Kosugi S, et al. Prolonged effects of recombinant human interleukin-1α on mouse thyroid function. Endocrinology 1990;127:2322-2327
69. van der Poll T, Van Zee KJ, Endert E, et al. Interleukin- 1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man. J Clin Endocrinol Metab 1995; 80:1341-1346
70. Boelen A, Platvoet-ter Schiphorst MC, Weirsinga WM. Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in non-thyroidal illness. J Clin Endocrinol Metab 1993;77:1695-1699
71. Davies PH, Black EG, Sheppard MC, Franklyn JA. Relationship between serum interleukin-6 and thyroid hormone concentrations in 270 hospitalized in-patients with non-thyroidal illness. Clin Endocrinol (Oxf) 1996;44:199-205
72. Murai H, Murakami S. Ishida K, Sugawara M. Elevated serum interleukin-6 and decreased thyroid hormone levels in postoperative patients and effects of Il-6 on thyroid cell function in vitro. Thyroid 1996;6:601-606
73. Boelen A, Platvoet MC, Wiersinga WM. Systematic and local illness in interleukin-6 knock-out mice: the role of Il-6 in the sick euthyroid syndrome. J Endocrinol Invest 1996;19:S79
74. Fernandez-Botran R. Soluble cytokine receptors: their role in immunoregulation. FASEB J 1991;5:2567-2574
75. Boelen A, Platvoet-ter Schiphorst MC, Wiersinga WM. Soluble cytokine receptors and the low 3,5,3′-triiodothyronine syndrome in patients with nonthyroidal disease. J Clin Endocrinol Metab 1995;80:971-976
76. Szabolcs I, Ploenes C, Bernard W, Herrmann J. Screening of geriatric patients for thyroid dysfunction with thyrotropin- releasing-hormone test, sensitive thyrotropin and free thyroxine estimation. Horm Metab Res 1990;22:298-302
77. Kaplan MM, Larsen PR, Crantz FR, et al. Prevalence of abnormal thyroid function test results in patients with acute medical illnesses. Am J Med 1982;72:9-16
78. Helfand M, Crapo L. Screening for thyroid disease. Ann Intern Med 1990;112:840-849
79. DeGroot IJ, Mayor G. Admission screening by thyroid function tests in an acute general care teaching hospital. Am J Med 1992;93:558-564
80. Liewendahl K. Mahonen H, Tikanoja S, et al. Performance of direct equilibrium dialysis and analogue-type free thyroid hormone assays, and an immunoradiometric TSH method in patients with thyroid dysfunction. Scand J Clin Lab Invest 1987;47:421-428
81. Nuutila P, Irjala K, Viikari J, et al. Comparative evaluation of serum thyroxine, free thyroxine and thyrotropin determinations in screening of thyroid function. Ann Clin Res 1988;20:158-163
82. Tikanoja S. Ultrafiltration devices tested for use in a free thyroxine assay validated by comparison with equilibrium dialysis. Scand J Clin Lab Invest 1990;50:663-669
83. Gavin LA, Rosenthal M, Cavalieri RR. The diagnostic dilemma of isolated hyperthyroxinemia in acute illness. JAMA 1979;242:251-253
84. Hawkins BR, Dawkins RL, Burger HG, et al. Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet 1980;2:1057-1059
85. Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly: microsomal antibodies as discriminant for therapy. JAMA 1987;258:209-213
86. Sawin CT, Bigos ST, Land S, Bacharach P. The aging thyroid: relationships between elevated serum thyrotropin level and thyroid antibodies in elderly patients. Am J Med 1985;79:591-595
87. Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low thyroxine concentration. J Clin Endocrinol Metab 1986;63:1-8
88. Becker RA, Vaughan GM, Zeigler MG, et al. Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med 1982;10:870-875
89. Braverman LE, Eber O, Langsteger W, eds. Heart and thyroid. Vienna: Blackwell-MZV, 1994
90. Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid, ed 7. Philadelphia: Lippincott-Raven, 1996
91. Hamilton MA, Brown PS, Weintraub BD, Clark RE. Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 1990;16:91-95
92. Hamilton MA. Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure. Ann Thorac Surg 1993;56:S48-S53
93. Morkin E, Pennock GD, Raya TE, et al. Studies on the use of thyroid hormone and a thyroid hormone analogue in the treatment of congestive heart failure. Ann Thorac Surg 1993;56:S54-S60
94. Ladenson PW. Recognition and management of cardiovascular disease related to thyroid dysfunction. Am J Med 1990;88:638-641
95. Tielens ET, Forder JR, Chatham JC, et al. Acute L-triiodothyronine administration potentiates ionotropic responses to beta-adrenergic stimulation in the isolated perfused rat heart. Cardiovasc Res 1996;32:306-310
96. Wiersinga WM, Lie KI, Touber JL. Thyroid hormones in acute myocardial infarction. Clin Endocrinol (Oxf) 1984;14:367-374
97. Worstman J, Premachandra BN, Chopra IJ, Murphy JE. Hypothyroxinemia in cardiac arrest. Arch Intern Med 1987;147:245-248
98. Longstreth WT, Manowitz NR, DeGroot LJ, et al. Plasma thyroid hormone profiles immediately following out-of- hospital cardiac arrest. Thyroid 1996;6:649-653
99. Facktor MA, Mayor GH, Nachreiner RF, D'Alecy LG. Thyroid hormone loss and replacement during resuscitation from cardiac arrest in dogs. Resuscitation 1993;26:141-162
100. Bremner WF, Taylor KM, Baird S, et al. Hypothalamopituitary-thyroid axis during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1978;75:392-399
101. Chu SH, Huang TS, Hsu RB, et al. Thyroid hormone changes after cardiovascular surgery and clinical implications. Ann Thorac Surg 1991;52:791-796
102. Robuschi G, Medici D, Fesani F, et al. Cardiopulmonary bypass: 'a low T4 and T3 syndrome' with blunted thyrotropin response to thyrotropin-releasing hormone. Horm Res 1986;23:151-158
103. Clark RE. Cardiopulmonary bypass and thyroid hormone metabolism. Ann Thorac Surg 1993;56:S35-S42
104. Reinhardt W, Mocker V, Jockenhovel F, et al. Influence of coronary artery bypass surgery on thyroid hormone parameters. Horm Res 1997;47:1-8
105. Holland FW, Brown PS, Weintraub BD, Clark RE. Cardiopulmonary bypass and thyroid function: a euthyroid sick syndrome. Ann Thorac Surg 1991;52:46-50
106. Broderick TJ, Wechsler AS. Triiodothyronine in cardiac surgery. Thyroid 1997;7:133-137
107. Novitzky D, Human PA, Cooper DKC. Ionotropic effect of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: an experimental study in pigs. Ann Thorac Surg 1988;45:50-55
108. Novitzky D, Human PA, Cooper DKC. Effect of triiodothyronine on myocardial high energy phophates and lactate after ischemia and cardiopulmonary bypass. J Thorac Cardiovasc Surg 1988;96:600-607
109. Novitzky D, Matthews N, Shawley D. Triiodothyronine replacement on the recovery of stunned myocardium in dogs. Ann Thorac Surg 1991;51:10-17
110. Novitzky D, Cooper DKC, Swanepoel A. Ionotropic effect of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: initial experience in patients undergoing open-heart surgery. Eur J Cardiothorac Surg 1989;3:140-145
111. Novitzky D, Cooper DKC, Barton CI. Triidothyronine as an ionotropic agent after open-heary surgery. J Thorac Cardiovasc Surg 1989;98:972-978
112. Teiger E, Menasche P, Mansier P, et al. Triidothyronine therapy in open-heart surgery: from hope to disappointment. Eur Heart J 1993;14:629-633
113. Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary artery bypass surgery. N Engl J Med 1995;333:1522-1527
114. Bennet-Guerrero E, Jimenez JL, White WD, et al. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass surgery. A randomized, double-blind, placebo-controlled trial. JAMA 1996;275: 687-692
115. Jeevanandam V. Triidothyronine: spectrum of use in heart transplantation. Thyroid 1997;7:139-145
116. Novitzky D. Novel actions of thyroid hormone: the role of triidothyronine in cardiac transplantation. Thyroid 1996;6: 531-536
117. Goarin J-P, Cohen S, Riou B, et al. The effects of triidothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg 1996;83:41-47
118. Jeevandam V, Todd B, Regillo T, et al. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant 1994;13:681-687